Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Nucleic Acid Isolation and Purification Market - Analysis, Trends & Forecasts to 2021 - Research and Markets

Research and Markets
Posted on: 22 Dec 17

The "Global Nucleic Acid Isolation and Purification Market 2017-2021" report has been added to Research and Markets' offering.

The report forecasts the global nucleic acid isolation and purification market to grow at a CAGR of 8.33% during the period 2017-2021.

The report, Global Nucleic Acid Isolation and Purification Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is increasing importance of promotional activities. The nature of product coupled with the niche end-user market makes it difficult for vendors to market these products. Unlike other analysis equipment, the brand and product visibility have a limited role in the sale of these devices. Emphasis is given to improve the distribution network and increase the availability of products to the end-users.

One driver in the market is the increasing occurrence of genetic disorder, cancer, and infectious diseases. The occurrence of genetic disorders, infectious diseases, and cancer is on the rise across the world. A genetic disorder is caused by an aberration in an individual's DNA. Aberrations can be as small as a single-base mutation in just one gene, or may involve the subtraction or addition of entire chromosome. Examples of genetic disorders include cystic fibrosis, thalassemia, and sickle cell anemia. Cancer is one of the major public health problems across the world and it is one of the leading causes of death. There are various types of cancer such as lung cancer, breast cancer, skin cancer, and colon cancer. In 2012, it was estimated that approximately 13.92 million new cases of cancer occur across the world.

Key vendors

  • Agilent Technologies
  • Bio-Rad Laboratories
  • F.Hoffmann-La-Roche
  • GE Healthcare
  • Thermo Fisher Scientific

Other prominent vendors

  • Abcam
  • Bioline
  • biotechrabbit
  • bioWORLD
  • Danaher
  • Epicentre
  • Hamilton
  • New England Biolabs
  • Omega Bio-tek
  • Promega
  • Qiagen
  • Sigma-Aldrich
  • Takara Bio

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation By End-User

Part 09: Geographical Segmentation

Part 10: Decision Framework

Part 11: Drivers And Challenges

Part 12: Market Trends

Part 13: Vendor Landscape

Part 14: Vendor Analysis

For more information about this report visit

View source version on

Business Wire

Last updated on: 22/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.